NICE on u/s-guided foam sclerotherapy:
This article was originally published in Clinica
Executive Summary
The UK National Institute for Health and Clinical Excellence (NICE) has deemed ultrasound-guided foam sclerotherapy to be effective in treating varicose veins in the short term. In an update of the interventional procedures (IP) guidance it issued on the technique in June 2006, NICE notes "transient side effects in a small proportion of patients", thereby requiring special arrangements for consent and audit/research. The guidance has been endorsed by NHS Quality Improvement Scotland, making it valid for the whole of the UK. However, IP appraisals do not assess clinical demand for the procedure - nor have they any legal weight - so provide no indication of their impact on the use of the technologies involved. The "special arrangements" attached to NICE's decisions on interventional procedures are the subject of an open consultation.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.